VIRAMUNE

This brand name is authorized in Austria, Australia, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VIRAMUNE contains one active pharmaceutical ingredient (API):

1 Nevirapine UNII 99DK7FVK1H - NEVIRAPINE

Nevirapine is a NNRTI of HIV-1. Nevirapine is a non-competitive inhibitor of the HIV-1 reverse transcriptase, but it does not have a biologically significant inhibitory effect on the HIV-2 reverse transcriptase or on eukaryotic DNA polymerases α, β, γ, or δ. Read about Nevirapine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AG01	Nevirapine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors
Discover more medicines within J05AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10303G, 10319D
Country: EE	Ravimiamet	Identifier(s): 1037113, 1082618, 1215380, 1422638, 1540279, 1540280, 1540291, 1540303
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 97055002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 133551, 383445, 403633
Country: FR	Base de données publique des médicaments	Identifier(s): 62228427, 63791738, 65501436, 69410368
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 44508
Country: HK	Department of Health Drug Office	Identifier(s): 44098, 61394
Country: IT	Agenzia del Farmaco	Identifier(s): 033999018, 033999020, 033999032, 033999044, 033999057, 033999069, 033999071, 033999083, 033999095
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250013F1023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1012281, 1012282, 1031182, 1056597, 1063659, 1063660, 1063661, 1063662, 1063663
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 550M98
Country: NL	Z-Index G-Standaard	Identifier(s): 14260638
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 49786, 52213, 99007, 99015
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8602
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100100276, 100253206, 100253212, 100253229, 100279393
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W13091001, W57321001, W57323001, W57323002, W57323003
Country: SG	Health Sciences Authority	Identifier(s): 10516P, 14299P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699693010056
Country: US	FDA, National Drug Code	Identifier(s): 0597-0046, 0597-0047, 0597-0123
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/20.2.8/0640, 33/20.2.8/0504